Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Systematic and combined endosonographic staging of lung cancer (SCORE study).

Crombag LMM, Dooms C, Stigt JA, Tournoy KG, Schuurbiers OCJ, Ninaber MK, Buikhuisen WA, Hashemi SMS, Bonta PI, Korevaar DA, Annema JT.

Eur Respir J. 2019 Feb 7;53(2). pii: 1800800. doi: 10.1183/13993003.00800-2018. Print 2019 Feb.

PMID:
30578389
2.

Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.

Frick AE, Nackaerts K, Moons J, Lievens Y, Verbeken E, Lambrecht M, Coolen J, Dooms C, Vansteenkiste J, De Leyn P, Nafteux P.

Eur J Cardiothorac Surg. 2018 Dec 6. doi: 10.1093/ejcts/ezy385. [Epub ahead of print]

PMID:
30535191
3.

Health Outcomes for Definite Concurrent Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study.

Nguyen PAH, Vercauter P, Verbeke L, Beelen R, Dooms C, Tournoy KG.

Respiration. 2018 Nov 22:1-9. doi: 10.1159/000493984. [Epub ahead of print]

PMID:
30466111
4.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.

Reynders K, Wauters E, Moisse M, Decaluwé H, De Leyn P, Peeters S, Lambrecht M, Nackaerts K, Dooms C, Janssens W, Vansteenkiste J, Lambrechts D, De Ruysscher D.

Radiat Oncol. 2018 Jul 17;13(1):131. doi: 10.1186/s13014-018-1075-1.

5.

A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer.

Dooms C, Vander Borght S, Yserbyt J, Testelmans D, Wauters E, Nackaerts K, Vansteenkiste J, Verbeken E, Weynand B.

Respiration. 2018;96(3):275-282. doi: 10.1159/000489473. Epub 2018 Jun 29.

PMID:
29961053
6.

Lung cancer staging: a concise update.

Rami-Porta R, Call S, Dooms C, Obiols C, Sánchez M, Travis WD, Vollmer I.

Eur Respir J. 2018 May 17;51(5). pii: 1800190. doi: 10.1183/13993003.00190-2018. Print 2018 May.

PMID:
29700105
7.

Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease.

Decaluwé H, Dooms C, De Leyn P, Thomas P, Rami-Porta R.

Eur Respir J. 2018 Apr 4;51(4). pii: 1800410. doi: 10.1183/13993003.00410-2018. Print 2018 Apr. No abstract available.

PMID:
29618606
8.

Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?

Decaluwé H, Moons J, Fieuws S, De Wever W, Deroose C, Stanzi A, Depypere L, Nackaerts K, Coolen J, Lambrecht M, Verbeken E, De Ruysscher D, Vansteenkiste J, Van Raemdonck D, De Leyn P, Dooms C; Leuven Lung Cancer Group.

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):134-140. doi: 10.1093/ejcts/ezy018.

PMID:
29447330
9.

Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.

Leemans J, Dooms C, Ninane V, Yserbyt J.

Respirology. 2018 Jun;23(6):613-617. doi: 10.1111/resp.13252. Epub 2018 Jan 10.

PMID:
29320805
10.

Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.

Decaluwé H, Dooms C, D'Journo XB, Call S, Sanchez D, Haager B, Beelen R, Kara V, Klikovits T, Aigner C, Tournoy K, Zahin M, Moons J, Brioude G, Trujillo JC, Klepetko W, Turna A, Passlick B, Molins L, Rami-Porta R, Thomas P, Leyn P.

Eur Respir J. 2017 Dec 21;50(6). pii: 1701493. doi: 10.1183/13993003.01493-2017. Print 2017 Dec.

PMID:
29269579
11.

Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.

Decaluwé H, Petersen RH, Brunelli A, Pompili C, Seguin-Givelet A, Gust L, Aigner C, Falcoz PE, Rinieri P, Augustin F, Sokolow Y, Verhagen A, Depypere L, Papagiannopoulos K, Gossot D, D'Journo XB, Guerrera F, Baste JM, Schmid T, Stanzi A, Van Raemdonck D, Bardet J, Thomas PA, Massard G, Fieuws S, Moons J, Dooms C, De Leyn P, Hansen HJ; MITIG-ESTS.

Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093/ejcts/ezx338. [Epub ahead of print]

PMID:
29029062
12.

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).

Dutau H, Breen D, Bugalho A, Dalar L, Daniels J, Dooms C, Eberhardt R, Ek L, Encheva M, Febvre M, Hackl M, Marran S, Papai-Szekely Z, Perch M, Roglic M, Rosell A, Rozman A, Shah PL, Simon M, Szlubowski A, Stratakos G, Sundset A, Uibu T, Von Garnier C, Zaric B, Zdraveska M, Zuccatosta L, Bokan D, Arshad Husain S, Bilaceroglu S, Gasche-Soccal P, Gasparini S, Herth FJF, Munavvar M.

Respiration. 2018;95(1):44-54. doi: 10.1159/000480152. Epub 2017 Sep 8.

13.

Endoscopic advanced imaging of the respiratory tract: exploring probe-based confocal laser endomicroscopy in emphysema.

Yserbyt J, Dooms C, Janssens W, Verleden GM.

Thorax. 2018 Feb;73(2):188-190. doi: 10.1136/thoraxjnl-2016-209746. Epub 2017 Apr 14.

PMID:
28411249
14.

Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study.

Van den Bosch L, Defraene G, Peeters S, Dooms C, De Wever W, Deroose C, De Ruysscher D.

Acta Oncol. 2017 Apr;56(4):541-547. doi: 10.1080/0284186X.2017.1293288. Epub 2017 Feb 26.

PMID:
28358665
15.

The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database.

Vrancken A, Lepers S, Peeters L, Oyen C, Dooms C, Nackaerts K, Verbeken E, Wauters I, Weynand B, Vansteenkiste J.

Lung Cancer. 2016 Dec;102:96-100. doi: 10.1016/j.lungcan.2016.11.003. Epub 2016 Nov 6.

PMID:
27987596
16.

Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection.

Billiet C, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, Hendrikx M, De Leyn P, Bulens P, Karim R, Le Péchoux C, Mebis J, De Ruysscher D.

J Thorac Oncol. 2016 Nov;11(11):1940-1953. doi: 10.1016/j.jtho.2016.06.018. Epub 2016 Jul 5.

17.

Five-Year Survival After Endosonography vs Mediastinoscopy for Mediastinal Nodal Staging of Lung Cancer.

Kuijvenhoven JC, Korevaar DA, Tournoy KG, Malfait TL, Dooms C, Rintoul RC, Annema JT.

JAMA. 2016 Sep 13;316(10):1110-2. doi: 10.1001/jama.2016.10349. No abstract available.

PMID:
27623466
18.

1,25-Dihydroxyvitamin D Modulates Antibacterial and Inflammatory Response in Human Cigarette Smoke-Exposed Macrophages.

Heulens N, Korf H, Mathyssen C, Everaerts S, De Smidt E, Dooms C, Yserbyt J, Gysemans C, Gayan-Ramirez G, Mathieu C, Janssens W.

PLoS One. 2016 Aug 11;11(8):e0160482. doi: 10.1371/journal.pone.0160482. eCollection 2016.

19.

Rebuttal from Dr. Decaluwé and Dr. Dooms.

Decaluwé H, Dooms C.

Transl Lung Cancer Res. 2016 Jun;5(3):256-7. doi: 10.21037/tlcr.2016.06.12. No abstract available.

20.

Cons: should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?

Decaluwé H, Dooms C.

Transl Lung Cancer Res. 2016 Jun;5(3):251-3. doi: 10.21037/tlcr.2016.06.06. No abstract available.

21.

Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.

Billiet C, De Ruysscher D, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, De Leyn P, Hendrikx M, Bulens P, Le Péchoux C, Mebis J.

J Thorac Oncol. 2016 Sep;11(9):1538-49. doi: 10.1016/j.jtho.2016.05.037. Epub 2016 Jun 30.

22.

The Feasibility of Tracheal Oxygen Supplementation during Flexible Bronchoscopy.

Yserbyt J, De Maeyer N, Dooms C, Testelmans D, Muylle I, Bruyneel M, Ninane V.

Respiration. 2016;92(1):48-52. doi: 10.1159/000447519. Epub 2016 Jun 30.

23.

Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?

Peeters ST, Dooms C, Van Baardwijk A, Dingemans AM, Martinussen H, Vansteenkiste J, Decaluwé H, De Leyn P, Yserbyt J, Nackaerts K, De Wever W, Deroose CM, De Ruysscher D.

Radiother Oncol. 2016 Aug;120(2):273-8. doi: 10.1016/j.radonc.2016.05.023. Epub 2016 Jun 10.

PMID:
27291644
24.

Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma.

Louis E, Adriaensens P, Guedens W, Bigirumurame T, Baeten K, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, Shkedy Z, Mesotten L, Thomeer M.

J Thorac Oncol. 2016 Apr;11(4):516-23. doi: 10.1016/j.jtho.2016.01.011. Epub 2016 Feb 29.

25.

Large Bronchopleural Fistula After Surgical Resection: Secret to Success.

Delanote I, Budts W, De Leyn P, Dooms C.

J Thorac Oncol. 2016 Feb;11(2):268-9. doi: 10.1016/j.jtho.2015.09.011. Epub 2015 Dec 19. No abstract available.

26.

Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.

Decaluwé H, Stanzi A, Dooms C, Fieuws S, Coosemans W, Depypere L, Deroose CM, Dewever W, Nafteux P, Peeters S, Van Veer H, Verbeken E, Van Raemdonck D, Moons J, De Leyn P; Leuven Lung Cancer Group.

Eur J Cardiothorac Surg. 2016 Jul;50(1):110-7. doi: 10.1093/ejcts/ezv489. Epub 2016 Jan 27.

PMID:
26819286
27.

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.

Dietel M, Bubendorf L, Dingemans AM, Dooms C, Elmberger G, García RC, Kerr KM, Lim E, López-Ríos F, Thunnissen E, Van Schil PE, von Laffert M.

Thorax. 2016 Feb;71(2):177-84. doi: 10.1136/thoraxjnl-2014-206677. Epub 2015 Nov 3. Review.

28.

Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?

Louis E, Adriaensens P, Guedens W, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, de Jonge E, Thomeer M, Mesotten L.

Ann Oncol. 2016 Jan;27(1):178-84. doi: 10.1093/annonc/mdv499. Epub 2015 Oct 20.

PMID:
26487580
29.

Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome-a single-centre experience.

Yserbyt J, Dooms C, Vos R, Dupont LJ, Van Raemdonck DE, Verleden GM.

Eur J Cardiothorac Surg. 2016 Jan;49(1):e1-8. doi: 10.1093/ejcts/ezv363. Epub 2015 Oct 13.

PMID:
26464447
30.

CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.

Vercauteren IM, Verleden SE, McDonough JE, Vandermeulen E, Ruttens D, Lammertyn EJ, Bellon H, De Dycker E, Dooms C, Yserbyt J, Verleden GM, Vanaudenaerde BM, Wuyts WA.

Exp Lung Res. 2015;41(8):459-65. doi: 10.3109/01902148.2015.1073407.

PMID:
26381718
31.

The inner and outer of our thorax: silicone breast implants and pulmonary alveolar proteinosis.

De Backer H, Darquennes K, Dooms C, Yserbyt J, Coolen J, Verschakelen J, Verbeken E, Vrints I, Wuyts W.

Acta Clin Belg. 2015 Oct;70(5):384-6. doi: 10.1179/2295333715Y.0000000035. Epub 2015 Jun 17.

PMID:
26083574
32.

Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations.

Vliegen L, Dooms C, De Kelver W, Verbeken E, Vansteenkiste J, Vandenberghe P.

Diagn Pathol. 2015 May 29;10:57. doi: 10.1186/s13000-015-0293-1.

33.

Lung cancer at the intensive care unit: The era of targeted therapy.

Adam V, Dooms C, Vansteenkiste J.

Lung Cancer. 2015 Aug;89(2):218-21. doi: 10.1016/j.lungcan.2015.05.009. Epub 2015 May 18.

PMID:
26022271
34.

To boldly go where no bronchoscope has gone before.

Yserbyt J, Dupont L, Ninane V, Dooms C.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):956. doi: 10.1164/rccm.201410-1920IM. No abstract available.

PMID:
25876204
35.

Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines.

De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, Turna A, Van Schil P, Venuta F, Waller D, Weder W, Zielinski M.

Transl Lung Cancer Res. 2014 Aug;3(4):225-33. doi: 10.3978/j.issn.2218-6751.2014.08.05. Review.

36.

Response.

Dooms C, Tournoy K.

Chest. 2015 Mar;147(3):e122-e123. doi: 10.1378/chest.14-3079. No abstract available.

PMID:
25732468
37.

Principles of rehabilitation and reactivation.

Osadnik CR, Rodrigues FM, Camillo CA, Loeckx M, Janssens W, Dooms C, Troosters T.

Respiration. 2015;89(1):2-11. doi: 10.1159/000370246. Epub 2015 Jan 13. Review.

38.

Computed tomography characteristics predictive for radial EBUS-miniprobe-guided diagnosis of pulmonary lesions.

Guvenc C, Yserbyt J, Testelmans D, Zanca F, Carbonez A, Ninane V, De Wever W, Dooms C.

J Thorac Oncol. 2015 Mar;10(3):472-8. doi: 10.1097/JTO.0000000000000410.

39.

Suitability of small bronchoscopic tumour specimens for lung cancer genotyping.

Dooms C, Vliegen L, Vander Borght S, Yserbyt J, Hantson I, Verbeken E, Wauters E, Nackaerts K, Ninane V, Vansteenkiste J, Vandenberghe P.

Respiration. 2014;88(5):371-7. doi: 10.1159/000366136. Epub 2014 Oct 9.

40.

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study.

Hantson I, Dooms C, Verbeken E, Vandenberghe P, Vliegen L, Roskams T, Vander Borght S, Nackaerts K, Wauters I, Vansteenkiste J.

Transl Respir Med. 2014 Dec;2(1):9. doi: 10.1186/s40247-014-0009-0. Epub 2014 Sep 11.

41.

Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging.

Coolen J, De Keyzer F, Nafteux P, De Wever W, Dooms C, Vansteenkiste J, Derweduwen A, Roebben I, Verbeken E, De Leyn P, Van Raemdonck D, Nackaerts K, Dymarkowski S, Verschakelen J.

Radiology. 2015 Feb;274(2):576-84. doi: 10.1148/radiol.14132111. Epub 2014 Sep 19.

PMID:
25243538
42.

Endosonography for mediastinal nodal staging of clinical N1 non-small cell lung cancer: a prospective multicenter study.

Dooms C, Tournoy KG, Schuurbiers O, Decaluwe H, De Ryck F, Verhagen A, Beelen R, van der Heijden E, De Leyn P.

Chest. 2015 Jan;147(1):209-215. doi: 10.1378/chest.14-0534.

PMID:
25211526
43.

Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy.

De Raedt N, Gheysens O, Nackaerts K, Dooms C, De Ruysscher D, Deroose CM.

Am J Respir Crit Care Med. 2014 Aug 15;190(4):e12-3. doi: 10.1164/rccm.201309-1637IM. No abstract available.

PMID:
25127312
44.

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

Blackhall FH, Peters S, Bubendorf L, Dafni U, Kerr KM, Hager H, Soltermann A, O'Byrne KJ, Dooms C, Sejda A, Hernández-Losa J, Marchetti A, Savic S, Tan Q, Thunnissen E, Speel EJ, Cheney R, Nonaka D, de Jong J, Martorell M, Letovanec I, Rosell R, Stahel RA.

J Clin Oncol. 2014 Sep 1;32(25):2780-7. doi: 10.1200/JCO.2013.54.5921. Epub 2014 Jul 28.

PMID:
25071109
45.

Acute lung allograft rejection: diagnostic role of probe-based confocal laser endomicroscopy of the respiratory tract.

Yserbyt J, Dooms C, Decramer M, Verleden GM.

J Heart Lung Transplant. 2014 May;33(5):492-8. doi: 10.1016/j.healun.2014.01.857. Epub 2014 Jan 24.

PMID:
24656287
46.

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, Turna A, Van Schil P, Venuta F, Waller D, Weder W, Zielinski M.

Eur J Cardiothorac Surg. 2014 May;45(5):787-98. doi: 10.1093/ejcts/ezu028. Epub 2014 Feb 26.

47.

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Vansteenkiste J, Crinò L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, Stahel R, Peters S, Felip E; Panel Members.

Ann Oncol. 2014 Aug;25(8):1462-74. doi: 10.1093/annonc/mdu089. Epub 2014 Feb 20.

48.

Bronchial valve treatment for pulmonary air leak after anatomical lung resection for cancer.

Dooms CA, Decaluwe H, Yserbyt J, De Leyn P, Van Raemdonck D, Ninane V.

Eur Respir J. 2014 Apr;43(4):1142-8. doi: 10.1183/09031936.00117613. Epub 2013 Nov 14.

49.

Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging.

Coolen J, Vansteenkiste J, De Keyzer F, Decaluwé H, De Wever W, Deroose C, Dooms C, Verbeken E, De Leyn P, Vandecaveye V, Van Raemdonck D, Nackaerts K, Dymarkowski S, Verschakelen J.

Eur Radiol. 2014 Feb;24(2):531-41. doi: 10.1007/s00330-013-3053-1. Epub 2013 Oct 31.

PMID:
24173597
50.

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.

Billiet C, Decaluwé H, Peeters S, Vansteenkiste J, Dooms C, Haustermans K, De Leyn P, De Ruysscher D.

Radiother Oncol. 2014 Jan;110(1):3-8. doi: 10.1016/j.radonc.2013.08.011. Epub 2013 Oct 4. Review. Erratum in: Radiother Oncol. 2014 Nov;113(2):300-1.

PMID:
24100149

Supplemental Content

Support Center